NHGRI Starts Phase II of Long-Range Planning

May 01, 2009

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute has started the second phase of its long-term planning process, and has called on the research community and interested parties to comment on recent updates it has made to a series of white papers it released at the end of last year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Another Look

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

Some More Than Others

A new analysis finds some cancers receive more nonprofit dollars than others.

Gene Variant's Possible Role

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

Science Finds Sex-Biased Gene Expression in Mammals, More

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.

Featured White Papers

Single-Cell Cloning for Cell Line Development

Genetic Testing as a Tool for Improving Care and Outcomes for Patients with Rare Inherited Retinal Diseases

Cell Engineering 101

Improved CRISPR Knockout Efficiency Using an Automated Optimization Workflow

Jul

23

Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

30

Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Aug

28

Featured Webinar

Beyond Cas9: CRISPR Gene Editing with Alternative Nucleases

This webinar will provide an overview of alternatives to the popular Cas9 nuclease used in CRISPR gene editing.

Menu